Join
Live feed
·
ANALYSTRatingvia Quantisnow
AgomAb Therapeutics NV logo

Cantor Fitzgerald initiated coverage on AgomAb Therapeutics NV

ByQuantisnow·Wall Street's wire, on your screen.
AGMB· AgomAb Therapeutics NV
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AGMB (AgomAb Therapeutics NV) and more on Quantisnow.